Transplantation of Fetal Midbrain Dopamine Progenitors into a Rodent Model of Parkinson’s Disease
- 15 July 2013
- book chapter
- Published by Springer Nature
- Vol. 1059, 169-180
Abstract
Cell therapy is a promising experimental treatment for Parkinson’s disease (PD). It is based on the idea that new dopamine neurons transplanted directly into the forebrain of the patient can structurally and functionally compensate for those lost to the disease in order to restore motor function. While there is a highly active field of research focused on the development of stem cell-based procedures, fetal tissue remains the “gold standard” as a safe and reliable source of dopamine neuron progenitors capable of structural and functional integration with existing motor circuitry following transplantation. This chapter describes the basic procedures for preparation of dopamine progenitor rich cell suspensions of ventral mesencephalon as well as implantation into the unilateral 6-hydroxydopamine model of PD and assessment of functional impact according to drug-induced rotational behavior. The description assumes a basic knowledge of animal handling and stereotaxic surgical procedures in rodents.Keywords
This publication has 12 references indexed in Scilit:
- Serotonin Neuron Transplants Exacerbate l-DOPA- Induced Dyskinesias in a Rat Model of Parkinson's DiseaseJournal of Neuroscience, 2007
- Improved survival of young donor age dopamine grafts in a rat model of Parkinson’s diseaseNeuroscience, 2007
- Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in miceBehavioural Brain Research, 2005
- Cell transplantation in Parkinson's disease: how can we make it work?Trends in Neurosciences, 2005
- A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal functionNeurobiology of Disease, 2004
- Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the RatExperimental Neurology, 1998
- Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the ratNeuroscience, 1996
- Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson modelBrain Research, 1994
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplantsBrain Research, 1979
- Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine SystemScience, 1979